To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

XLP Research Trust


60 Winchester Road
Hampshire, SO51 8JA United Kingdom



Email Address

[email protected]


The XLP Research Trust exists to promote and fund research on this disorder, provide a point of contact and support for families affected by XLP, and raise awareness of the disorder among medical professionals and the public. X-linked lymphoproliferative syndrome (XLP), which is also known as Duncan's syndrome, is an extremely rare, inherited immunodeficiency disorder that is usually fully expressed in males only. To date, more than 400 boys from 100 families have been diagnosed. Boys who have this disease have a faulty immune system and are unable to fight off infections, leading to chronic, life-threatening illness in many cases.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.